Long-term anticoagulation in the extreme elderly with the newer antithrombotics: safe or sorry?

about

Novel Anticoagulants in Atrial Fibrillation: Monitoring, Reversal and Perioperative Management

P2860

Q26801895-9FF5E1BB-E93D-4766-95BA-89650C8F3F41

P2860

Long-term anticoagulation in the extreme elderly with the newer antithrombotics: safe or sorry?

Item

http://www.wikidata.org/entity/Q36909458

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Long-term anticoagulation in t ...... ntithrombotics: safe or sorry?

@en

type

Item

label

Long-term anticoagulation in t ...... ntithrombotics: safe or sorry?

@en

prefLabel

Long-term anticoagulation in t ...... ntithrombotics: safe or sorry?

@en

P1476

Long-term anticoagulation in t ...... ntithrombotics: safe or sorry?

@en

P2093

Jun R Chiong

http://www.w3.org/2001/XMLSchema#string

Rebecca J Cheung

http://www.w3.org/2001/XMLSchema#string

P2860

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

Dabigatran versus warfarin in patients with atrial fibrillation

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years.

Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.

Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial.

Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.

P304

287-292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4070/KCJ.2013.43.5.287

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237098483

http://www.w3.org/2001/XMLSchema#string

P698

23755073

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

3675301

http://www.w3.org/2001/XMLSchema#string

Long-term anticoagulation in the extreme elderly with the newer antithrombotics: safe or sorry?

about

P2860

P2860

Long-term anticoagulation in the extreme elderly with the newer antithrombotics: safe or sorry?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932